Research programme: muscle regeneration peptides - StemPath
Latest Information Update: 16 Jul 2016
At a glance
- Originator StemPath
- Class
- Mechanism of Action Stem cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cachexia; Muscular dystrophies; Urinary incontinence
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cachexia in Canada
- 16 Jul 2016 No recent reports of development identified for preclinical development in Muscular-dystrophies in Canada
- 16 Jul 2016 No recent reports of development identified for preclinical development in Urinary-incontinence in Canada